EP 1480950 A4 20050518 - NOVEL CRYSTAL FORMS OF ATORVASTATIN HEMI-CALCIUM AND PROCESSES FOR THEIR PREPARATION, AS WELL AS NOVEL PROCESSES FOR PREPARING ATORVASTATIN HEMI-CALCIUM FORMS I, VIII AND IX
Title (en)
NOVEL CRYSTAL FORMS OF ATORVASTATIN HEMI-CALCIUM AND PROCESSES FOR THEIR PREPARATION, AS WELL AS NOVEL PROCESSES FOR PREPARING ATORVASTATIN HEMI-CALCIUM FORMS I, VIII AND IX
Title (de)
NEUE KRISTALLFORMEN VON ATORVASTATIN-HEMICALCIUM UND VERFAHREN ZU DEREN HERSTELLUNG, SOWIE NEUE VERFAHREN ZUR HERSTELLUNG DER FORMEN I, VIII UND IX VON ATORVASTATIN-HEMICALCIUM
Title (fr)
NOUVELLES FORMES CRISTALLINES D'HEMI-CALCIUM D'ATORVASTATINE ET PROCEDES POUR LEUR PREPARATION, AINSI QUE PROCEDES NOUVEAUX POUR LA PREPARATION DES FORMES I,VIII ET IX D'HEMI-CALCIUM D'ATORVASTATINE
Publication
Application
Priority
- US 0305384 W 20030219
- US 35718102 P 20020215
- US 42532502 P 20021112
Abstract (en)
[origin: WO03070702A1] The present invention provides novel forms of atorvastatin designated Forms IXa, XIV, XVI and XVII and novel processes for their preparation as well as processes for preparing atorvastatin hemi-calcium Forms I, XIII and IX.
IPC 1-7
IPC 8 full level
A61K 31/40 (2006.01); A61P 3/06 (2006.01); C07D 207/327 (2006.01); C07D 207/34 (2006.01); C07D 405/06 (2006.01)
CPC (source: EP KR)
A61K 31/40 (2013.01 - KR); A61P 3/06 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 207/327 (2013.01 - KR); C07D 207/34 (2013.01 - EP); C07D 405/06 (2013.01 - EP)
Citation (search report)
- [X] WO 9703958 A1 19970206 - WARNER LAMBERT CO [US], et al
- [X] WO 9703959 A1 19970206 - WARNER LAMBERT CO [US], et al
- [X] WO 0136384 A1 20010525 - TEVA PHARMA [IL], et al
- [X] WO 0144180 A1 20010621 - WARNER LAMBERT RES & DEV IE [IE], et al
- [X] WO 0144181 A1 20010621 - WARNER LAMBERT RES & DEV IE [IE], et al
- [PX] WO 0241834 A2 20020530 - TEVA PHARMA [IL], et al
- [PX] WO 0243732 A1 20020606 - TEVA PHARMA [IL], et al
- [PX] WO 02051804 A1 20020704 - CIBA SC HOLDING AG [CH], et al
- [PX] WO 02057229 A1 20020725 - BIOCON LTD [IN], et al
- [PX] WO 03004470 A1 20030116 - WARNER LAMBERT CO [US], et al
- [PX] WO 03011826 A1 20030213 - REDDYS LAB LTD DR [IN], et al
- [E] WO 03050085 A1 20030619 - IVAX CORP [US], et al
- [E] WO 2004022053 A1 20040318 - MOREPEN LAB LTD [IN], et al
- [E] WO 2004050618 A2 20040617 - TEVA PHARMA [IL], et al
- See references of WO 03070702A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR
DOCDB simple family (publication)
WO 03070702 A1 20030828; AU 2003217653 A1 20030909; CA 2475864 A1 20030828; CN 100406436 C 20080730; CN 1646490 A 20050727; DE 03713610 T1 20051020; EP 1480950 A1 20041201; EP 1480950 A4 20050518; ES 2241507 T1 20051101; HR P20040768 A2 20050630; IS 7402 A 20040813; JP 2005519076 A 20050630; JP 2009235083 A 20091015; KR 100724515 B1 20070604; KR 20040081202 A 20040920; MX PA04007939 A 20041126; NO 20043842 L 20040914; PL 372303 A1 20050711
DOCDB simple family (application)
US 0305384 W 20030219; AU 2003217653 A 20030219; CA 2475864 A 20030219; CN 03808207 A 20030219; DE 03713610 T 20030219; EP 03713610 A 20030219; ES 03713610 T 20030219; HR P20040768 A 20040825; IS 7402 A 20040813; JP 2003569609 A 20030219; JP 2009137400 A 20090608; KR 20047012591 A 20030219; MX PA04007939 A 20030219; NO 20043842 A 20040914; PL 37230303 A 20030219